DES and neoplasm: In the tumor samples available for immunohistochemistry, heterogeneous desmin positivity (12/13), inconstant MYOD1 (12/13) and myogenin (9/13) expression, and at least partial ALK (9/13) positivity were observed (Fig. 1a, b and Supplementary Fig. 1).